中国癌症杂志 ›› 2022, Vol. 32 ›› Issue (1): 80-89.doi: 10.19401/j.cnki.1007-3639.2022.01.011

• 指南与共识 • 上一篇    下一篇

中国乳腺癌新辅助治疗专家共识(2022年版)

《中国乳腺癌新辅助治疗专家共识(2022年版)》专家组()   

  • 收稿日期:2021-12-18 出版日期:2022-01-30 发布日期:2022-01-30
  • 通信作者: 《中国乳腺癌新辅助治疗专家共识(2022年版)》专家组 E-mail:zhimingshao@yahoo.com

Expert consensus on neoadjuvant treatment of breast cancer in China (2022 edition)

Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2022 edition) ()   

  • Received:2021-12-18 Published:2022-01-30 Online:2022-01-30
  • Contact: Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2022 edition) E-mail:zhimingshao@yahoo.com

摘要:

新辅助治疗已经成为乳腺癌综合治疗中非常重要的组成部分,2019年中国乳腺癌新辅助治疗专家组就新辅助治疗的目的、适应证、评估规范、手术治疗原则及新辅助系统治疗的策略进行了详细探讨和阐述,结合近两年新的循证医学证据和学术理念,对新辅助治疗临床实施规范和治疗原则予以更新和说明。

关键词: 乳腺癌, 新辅助治疗, 共识

Abstract:

Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and the treatment strategy of neoadjuvant therapy. We further updated and discussed the clinical implementations and treatment principles of neoadjuvant therapy.

Key words: Breast cancer, Neoadjuvant treatment, Consensus

中图分类号: